Literature DB >> 11972706

Molecular epidemiology of cystic fibrosis-linked Burkholderia cepacia complex isolates from three national referral centres in Ireland.

D Crowley1, M Daly, B Lucey, P Shine, J J Collins, B Cryan, J E Moore, P Murphy, G Buckley, S Fanning.   

Abstract

AIMS: Burkholderia cepacia is a Gram-negative bacterium associated with increasing morbidity and mortality and is readily transmitted among infected cystic fibrosis (CF) patients. The B. cepacia complex consists of five distinct subgroups, termed genomovars. A collection of 17 presumptive B. cepacia isolates, obtained from three national CF referral centres located in different geographical regions in Ireland, was studied. The aim of this study was to investigate these isolates using molecular subtyping protocols for evidence of genetic relationships and for the presence of antibiotic resistance-encoding class 1 integron structures. METHODS AND
RESULTS: Genomovar classifications were assigned to each isolate based on HaeIII enzyme profiles of their recA locus. Genetic relationships among this collection were also assessed after restriction fragment length polymorphism (RFLP)-mediated analysis of the 16S rDNA locus and DNA amplification fingerprinting (DAF). The surface expression of the cable pilus gene (cblA) may facilitate an early step in the infection process. All isolates were tested by amplification strategies for this marker. Burkholderia cepacia is known to be resistant to several antimicrobial agents. Resistance typing showed that the majority were resistant to three or more common antimicrobial agents. Five of the 17 isolates were resistant to sulphonamide, a characteristic linked with the presence of class 1 integrons. Gene cassettes containing beta-lactamase (oxa) and aminoglycoside acetyltransferase (aac(6')-1a) encoding genes were identified by polymerase chain reaction amplification.
CONCLUSIONS: Most of the isolates in this study were classified as genomovar III and were indistinguishable based on their corresponding 16S rDNA-RFLP profiles, whilst DAF further subtyped the collection. The cblA marker was identified in 47% of the isolates, many of which clustered in the genomovar III group. Class 1 integrons with recombined gene cassettes containing bla-OXA and aac(6')-1a genes were identified. SIGNIFICANCE AND IMPACT OF THE STUDY: This study demonstrates the application of molecular methods to investigate B. cepacia, a well-recognized human pathogen, cultured from Irish CF patients. Genomovar III was the most common genomic type identified. DNA fingerprinting further subtyped the latter isolates, facilitating a more detailed description of the molecular epidemiology. Drug resistance in these organisms can be explained, at least in part, by the presence of class 1 integrons. Development of targeted infection control strategies could be facilitated using these applied methods.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11972706     DOI: 10.1046/j.1365-2672.2002.01612.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  10 in total

1.  Class 2 integron with a novel cassette array in a Burkholderia cenocepacia isolate.

Authors:  María Soledad Ramírez; Liliana Jordá Vargas; Viviana Cagnoni; Marta Tokumoto; Daniela Centrón
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centre.

Authors:  G Golini; G Cazzola; R Fontana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-03       Impact factor: 3.267

Review 3.  Class 1 integron in staphylococci.

Authors:  Zhenbo Xu; Lin Li; Lei Shi; Mark E Shirtliff
Journal:  Mol Biol Rep       Date:  2011-01-22       Impact factor: 2.316

4.  OXA-46, a new class D beta-lactamase of narrow substrate specificity encoded by a blaVIM-1-containing integron from a Pseudomonas aeruginosa clinical isolate.

Authors:  Francesco Giuliani; Jean-Denis Docquier; Maria Letizia Riccio; Laura Pagani; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

5.  Molecular comparison of isolates of Burkholderia multivorans from patients with cystic fibrosis in the United Kingdom.

Authors:  Jane F Turton; Mary E Kaufmann; Nazim Mustafa; Sonia Kawa; Fiona E Clode; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

6.  Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit.

Authors:  T J Kidd; S C Bell; C Coulter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-27       Impact factor: 3.267

Review 7.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

8.  The contribution of antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates: an emphasis on efflux pump activity.

Authors:  Sung-Pin Tseng; Wan-Chi Tsai; Chih-Yuan Liang; Yin-Shiou Lin; Jun-Wei Huang; Chung-Yu Chang; Yu-Chang Tyan; Po-Liang Lu
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

Review 9.  Resistance integrons: class 1, 2 and 3 integrons.

Authors:  Yang Deng; Xuerui Bao; Lili Ji; Lei Chen; Junyan Liu; Jian Miao; Dingqiang Chen; Huawei Bian; Yanmei Li; Guangchao Yu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-10-20       Impact factor: 3.944

10.  Integrons: Vehicles and pathways for horizontal dissemination in bacteria.

Authors:  Sara Domingues; Gabriela J da Silva; Kaare M Nielsen
Journal:  Mob Genet Elements       Date:  2012-09-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.